Myosin
Myosin belongs to family of motor protein which transforms the chemical energy into mechanical energy via ATP hydrolysis. It is responsible for muscle contractions.
Products for Myosin
- Cat.No. Product Name Information
-
GC12341
(±)-Blebbistatin
(S)Blebbistatin
(±)-Blebbistatin is a racemic mixture containing two configurations, (+)-Blebbistatinb and (-)-Blebbistatin (Cat. No. GC13430). (±)-Blebbistatin can effectively inhibit the activity of non-muscle myosin II ATPase and the expression of various striated muscle myosins and non-muscle myosins in vertebrates. -
GC13430
(-)-Blebbistatin
(S)Blebbistatin
(-)-Blebbistatin is one of the configurations of the racemic mixture (±)-Blebbistatin (Cat. No. GC12341) and is the active form. (-)-Blebbistatin is a cell-permeable inhibitor of non-muscle myosin II ATPase, which effectively inhibits multiple striated muscle myosins as well as vertebrate non-muscle myosins with IC50 values ranging from 0.5-5μM, and only slightly inhibits smooth muscle myosin (IC50=80μM) . -
GC12996
(R)-(+)-Blebbistatin
(R)-Blebbistatin
(R)-(+)-Blebbistatin is the inactive enantiomer of (-)-Blebbistatin. -
GC71036
(R)-MPH-220
(R)-MPH-220 is the R isomer of MPH-220 .
-
GC63519
Aficamten
CK-274, CK-3773274
Aficamten (CK-274) is a potent cardiac myosin inhibitor with an IC50 of 1.4 μM. -
GC33254
ATM-3507
ATM-3507 is a potent tropomyosin inhibitor with IC50s from 3.83-6.84 μM in human melanoma cell lines.
-
GC35418
ATM-3507 trihydrochloride
ATM-3507 trihydrochloride is a potent tropomyosin inhibitor with IC50s from 3.83-6.84 μM in human melanoma cell lines.
-
GC16189
BTS
N-Benzyl-p-toluenesulfonamide, NSC 37123
potent inhibitor of Ca2+-stimulated myosin S1 ATPase -
GC11605
C-1
C-1 is a potent protein kinase inhibitor, with IC50s of 4 μM, 8 μM, 12 μM and 240 μM for cGMP-dependent protein kinase (PKG), cAMP-dependent protein kinase (PKA), protein kinase C (PKC) and MLC-kinase, respectively. C-1 also used as a ROCK inhibitor.
-
GC69307
JB002
JB002 is a myosin II inhibitor with an IC50 value of ≤10 μM. JB002 can be used for research on muscle spasms, chronic musculoskeletal pain, and hypertrophic cardiomyopathy.
-
GC69308
JB061
JB061 is a non-muscle myosin inhibitor with IC50 values of 4.4 μM (cardiac myosin), 9.1 μM (skeletal muscle myosin) and >100 μM (smooth muscle myosin II). JB061 has a low ability to inhibit ATPase activity (IC50>200 μM). JB061 exhibits cytotoxicity against COS-7 cells with an IC50 value of 39 μM.
-
GC71199
JB062
JB062 is a nonmuscle myosin inhibitor with IC50 values of 1.6, 5.4, and >100 μM for Skeletal muscle myosin, Cardiac muscle myosin, and Smooth muscle myosin II, respectively.
-
GC72814
Mavacamten-d5
MYK461-d5; SAR439152-d5
Mavacamten-d5 (MYK461-d5; SAR439152-d5) is deuterium labeled Mavacamten. -
GC11404
ML 9 hydrochloride
MLCK inhibitor
-
GC11411
ML-7 hydrochloride
A smooth muscle myosin light chain kinase inhibitor
-
GC13520
MLCK inhibitor peptide
inhibitor of myosin light chain kinase
-
GC17329
MLCK inhibitor peptide 18
Myosin Light Chain Kinase Inhibitor Peptide 18
Selective competitive inhibitor of myosin light chain kinase -
GC69494
MPH-220
MPH-220 is a selective, orally active inhibitor of skeletal muscle myosin-2 that causes muscle relaxation. It is an antispasmodic agent and can be used in the research of spasms and muscle stiffness.
-
GC33214
MS-444 (BE-34776)
BE-34776
MS-444 (BE-34776) inhibits the activity of purified smooth muscle myosin light chain kinase (MLCK) with an IC50 value of 10 μM. -
GC15858
MYK-461
MYK-461, SAR439152
MYK-461 (MYK461) is an orally active modulator of cardiac myosin, with IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively. -
GC69520
Myosin V-IN-1
Myosin V-IN-1 (compound 8) is an effective and selective inhibitor of Myosin V, with a Ki of 6 μM. Myosin V-IN-1 exhibits acute inhibitory effects on myosin V. It slows down the activation of myosin by specifically inhibiting the release of ADP from the actomyosin complex through inhibition of myosin V ATPase.
-
GC12832
Omecamtiv mecarbil
CK-1827452; CK1827452
Cardiac myosin activator -
GC63650
Pentachloropseudilin
Antibiotic A 15104 Y; PClP
Pentachloropseudilin (Antibiotic A 15104 Y; PClP) is a reversible and allosteric potent inhibitor of Myo1s (class 1 myosins) with IC50s range from 1 to 5 μM for mammalian class-1 myosins and greater than 90 μM for class-2 and class-5 myosins. Pentachloropseudilin is a potent inhibitor of transforming growth factor-β (TGF-β)-stimulated signaling, with an IC50 of 0.1 to 0.2 μM for TGF-β. -
GC69881
Sevasemten
Sevasemten is a conformational inhibitor of skeletal muscle myosin. Sevasemten selectively inhibits myosin with IC50 values of ≤ 10 μM (skeletal) or >100 μM (cardiac).